Deadlines Set for Securities Class Actions Against BBNX, FCEL, and HIMS

Key Facts

1Beta Bionics faces a class action lawsuit following FDA concerns over its iLet automated insulin delivery system.

2A November 10, 2026 deadline has been set for FuelCell Energy investors to seek lead plaintiff status in a securities fraud case.

3Hims & Hers Health faces a lawsuit stemming from an FTC complaint alleging serious business misconduct.

Law firms have issued alerts regarding upcoming lead plaintiff deadlines in securities class action lawsuits against Beta Bionics, FuelCell Energy, and Hims & Hers Health. Beta Bionics faces litigation following FDA concerns over its iLet insulin system, while a November 10, 2026 deadline has been set for FuelCell Energy investors to seek lead plaintiff status in a fraud case. According to a statement from Hagens Berman, Hims & Hers Health faces a lawsuit stemming from an FTC complaint alleging serious business misconduct.

FuelCell Energy, trading under the ticker FCEL, closed at $18.36 on October 7, 2026, while HIMS closed at $29.54 on the same date. The lawsuits allege that the companies made misleading statements regarding manufacturing capacity and financial performance, with Newsfile Corp reporting that FuelCell posted a net loss of $45.3 million in its financial results. In equity markets, BBNX closed at $18.08 on October 7, 2026, amid ongoing legal challenges impacting shareholder confidence.